ALDX News

Class Action Reminder from Pomerantz LLP for Investors of Aldeyra Therapeutics, Inc. – ALDX

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Disregarded FDA Requirements: Levi & Korsinsky

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Pomerantz LLP Updates Investors on Legal Action Brought Against Aldeyra Therapeutics, Inc. – ALDX

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Aldeyra Therapeutics, Inc. – ALDX

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Pomerantz LLP Shares Class Action Details With Shareholders in Aldeyra Therapeutics, Inc. – ALDX

ALDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 Ready to Announce with Confidence?

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!